9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Hoffmann-La Roche
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Sensei Biotherapeutics, Inc.
OncoC4, Inc.
Tempus AI
Cybrexa Therapeutics
Peking University